Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Thoracic Surgery

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 291 articles: HTML format

Single Articles

November 2024
1. VERGALLO R, Patrono C
   STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention.
   Eur Heart J. 2024 Nov 19:ehae773. doi: 10.1093.
   PubMed    
   
   
   
2. LI Z, Xiang D, Hu K
   Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure.
   Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093.
   PubMed    
   
   
   
3. MUNZEL T, Daiber A, Prochaska J
   How quitting, switching to e-cigarettes, or sticking to smoking shapes cardiovascular outcomes after percutaneous coronary intervention.
   Eur Heart J. 2024 Nov 11:ehae756. doi: 10.1093.
   PubMed    
   
   
   October 2024
4. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
   Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
   Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. KANG D, Choi KH, Kim H, Park H, et al
   Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
   Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. SANDNER S, Antoniades C, Caliskan E, Czerny M, et al
   Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoraci
   Eur Heart J. 2024 Oct 16:ehae654. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. 
   Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
   Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
   PubMed    
   
   
   September 2024
8. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
   Great debate: myocardial infarction after cardiac surgery must be redefined.
   Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
   PubMed    
   
   
   
9. SCHOFER N, Blankenberg S
   Transfemoral or surgical aortic valve replacement in young low-risk patients with tricuspid and bicuspid aortic valve stenosis.
   Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093.
   PubMed    
   
   
   
10. SATO M, Yoshijima N, Yashima F
    Sinus sequestration due to transcatheter heart valve endothelialization after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093.
    PubMed    
    
    
    
11. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    PubMed    
    
    
    
12. ACKERMANN P, Abdel-Wahab M, Noack T
    Macroscopic findings of severe structural valve deterioration of a transcatheter aortic bioprosthesis.
    Eur Heart J. 2024;45:3092.
    PubMed    
    
    
    
13. MARTINSSON A, Jeppsson A
    Invited editorial on "Outcome of aortic valve replacement versus conservative treatment in asymptomatic patients with severe aortic stenosis - Five years follow-up of the AVATAR randomized controlled trial" by Banovic et al.
    Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093.
    PubMed    
    
    
    
14. BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al
    Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial.
    Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
15. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al
    Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE.
    Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. VALGIMIGLI M, Landi A
    Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution.
    Eur Heart J. 2024 Aug 28:ehae542. doi: 10.1093.
    PubMed    
    
    
    
18. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
    Coronary artery disease management in older adults: revascularization and exercise training.
    Eur Heart J. 2024;45:2811-2823.
    PubMed     Abstract available
    
    
    
19. SCHELLER B, Zeller T
    Paclitaxel-coated balloons: the more you gain the more you get.
    Eur Heart J. 2024;45:2848-2850.
    PubMed    
    
    
    
20. BAI L, Feng Y, Chen M
    A very rare complication of transcatheter aortic valve replacement.
    Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093.
    PubMed    
    
    
    
21. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    PubMed    
    
    
    July 2024
22. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    PubMed    
    
    
    
25. CAFORIO ALP, Kaski JP, Gimeno JR, Elliott PM, et al
    Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
    Eur Heart J. 2024;45:2548-2569.
    PubMed     Abstract available
    
    
    
26. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    PubMed    
    
    
    
27. WANG J, Hu P, Ma XJ
    Mechanical mitral valve obstruction: gone with the wind.
    Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093.
    PubMed    
    
    
    
28. GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S
    Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery.
    Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093.
    PubMed    
    
    
    
29. BERNARD A, Deharo P, Fauchier L
    Time matters when considering treatment for patients with mitral regurgitation.
    Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093.
    PubMed    
    
    
    
30. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is there still a question to be answered?
    Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093.
    PubMed    
    
    
    
31. THYREGOD HGH, De Backer O, Sondergaard L
    A notion of bioprosthetic aortic valve durability.
    Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093.
    PubMed    
    
    
    June 2024
32. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    PubMed     Abstract available
    
    
    
34. ZHUANG Y, Wang W, Lu F
    Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral cervical approach.
    Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093.
    PubMed    
    
    
    
35. DOENST T, Faerber G
    Challenge-skill balance in cardiac surgery: an attempt to explain sex-related differences in coronary surgery.
    Eur Heart J. 2024 Jun 11:ehae350. doi: 10.1093.
    PubMed    
    
    
    
36. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    PubMed    
    
    
    
37. CREA F
    Optimizing the treatment of severe aortic stenosis.
    Eur Heart J. 2024;45:1861-1865.
    PubMed    
    
    
    
38. VERGALLO R, Pedicino D
    Weekly Journal Scan: transcatheter aortic valve implantation in patients with small aortic annulus.
    Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093.
    PubMed    
    
    
    May 2024
39. REN J, Bowyer A, Tian DH, Royse C, et al
    Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. MARIN-CUARTAS M, Tang GHL, Kiefer P, Fukuhara S, et al
    Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry.
    Eur Heart J. 2024 May 31:ehae292. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    PubMed    
    
    
    
45. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    PubMed     Abstract available
    
    
    
46. ROFFI M, Meier B, Gallino A
    Fifty years of percutaneous transluminal angioplasty.
    Eur Heart J. 2024;45:1779-1780.
    PubMed    
    
    
    
47. DVIR D, Tchetche D, Leon MB, Genereux P, et al
    Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
    Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
    Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
    Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    PubMed    
    
    
    April 2024
51. PIBAROT P
    Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
    Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
    PubMed    
    
    
    
52. KIM YY, Lluri G, Haeffele C, Daugherty T, et al
    Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
    Eur Heart J. 2024;45:1477-1480.
    PubMed    
    
    
    
53. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    PubMed    
    
    
    
54. BLEIZIFFER S
    Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
    Eur Heart J. 2024;45:1125-1126.
    PubMed    
    
    
    
55. WINDECKER S, Gilard M, Achenbach S, Cribier A, et al
    Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.
    Eur Heart J. 2024;45:1104-1115.
    PubMed     Abstract available
    
    
    
56. WAYDA B
    Machine perfusion of marginal donor hearts: a valuable tool, but where and for whom?
    Eur Heart J. 2024;45:1178.
    PubMed    
    
    
    
57. AMESZ JH, Taverne YJHJ, Manintveld OC
    To transplant or not to transplant 'marginal' donor hearts: is machine perfusion the answer?
    Eur Heart J. 2024;45:1177.
    PubMed    
    
    
    March 2024
58. FRANK D, Durand E, Lauck S, Muir DF, et al
    A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
    Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. BAKAR SN, Ong G, Fam NP
    LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
    Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
    PubMed    
    
    
    
60. 
    Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
    Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
    PubMed    
    
    
    
61. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
    Great debate: symptomatic moderate aortic stenosis should undergo intervention.
    Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
    PubMed    
    
    
    
62. MARTINSSON A, Rasalingam R, Jeppsson A
    Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
    Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
    PubMed    
    
    
    
63. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    PubMed    
    
    
    
64. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    PubMed    
    
    
    
65. MEHILLI J
    Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
    Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
    PubMed    
    
    
    
66. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
    Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. MAISANO F, Hahn R, Sorajja P, Praz F, et al
    Transcatheter treatment of the tricuspid valve: current status and perspectives.
    Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
68. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    PubMed    
    
    
    
69. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    PubMed    
    
    
    
70. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    PubMed    
    
    
    
71. LUDWIG S, Granada JF
    Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
    Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
    PubMed    
    
    
    
72. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
73. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    PubMed    
    
    
    
74. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    PubMed    
    
    
    
75. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
    Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. CAPRANZANO P, Moliterno D, Capodanno D
    Aspirin-free antiplatelet strategies after percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 18:ehad876. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. NAKAMURA K, Taniguchi T, Furukawa Y
    Haemolytic anaemia after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
    PubMed    
    
    
    
80. VERGALLO R, Galiuto L
    Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
    Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
    PubMed    
    
    
    
81. HAMILTON DE, Albright J, Seth M, Painter I, et al
    Merging machine learning and patient preference: a novel tool for risk prediction of percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 17:ehad836. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. ABOULHOSN J
    Sapien S3 transcatheter pulmonary valve replacement: an excellent option but not a panacea.
    Eur Heart J. 2024;45:211-213.
    PubMed    
    
    
    
83. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
    Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
    Eur Heart J. 2024;45:198-210.
    PubMed     Abstract available
    
    
    
84. SIONTIS GCM, Coles B, Haner JD, McGovern L, et al
    Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.
    Eur Heart J. 2024;45:161-177.
    PubMed     Abstract available
    
    
    
85. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
    Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. KADDOURA R, Al-Hijji M
    The evolution of transcatheter valvular interventions: current evidence.
    Eur Heart J. 2024;45:10-14.
    PubMed    
    
    
    December 2023
87. HUANG F, Ammirati E, Ponnaiah M, Montero S, et al
    Fulminant myocarditis proven by early biopsy and outcomes.
    Eur Heart J. 2023;44:5110-5124.
    PubMed     Abstract available
    
    
    
88. LI XM, Zhu XJ, Jing ZC
    Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
    Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
    PubMed    
    
    
    
89. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    PubMed    
    
    
    
90. BIENSTOCK SW, Stone GW
    From TriValve to TRILUMINATE to TRISCEND: what have we learned?
    Eur Heart J. 2023;44:4874-4877.
    PubMed    
    
    
    
91. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    PubMed    
    
    
    
92. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    PubMed    
    
    
    
93. FLORES-UMANZOR E, Cepas-Guillen P, Freixa X
    Enhancing success rate in transcatheter closure of paravalvular leaks post-TAVI with vascular plug technology.
    Eur Heart J. 2023;44:4810.
    PubMed    
    
    
    November 2023
94. VERGALLO R, Volpe M
    Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
    Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
    PubMed    
    
    
    
95. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    PubMed    
    
    
    
96. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    PubMed    
    
    
    
97. WAYDA B, Angleitner P, Smits JM, van Kins A, et al
    Disparities in donor heart acceptance between the USA and Europe: clinical implications.
    Eur Heart J. 2023;44:4665-4674.
    PubMed     Abstract available
    
    
    
98. ZHAO Y, Chen Y
    What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
    Eur Heart J. 2023 Nov 20:ehad728. doi: 10.1093.
    PubMed    
    
    
    
99. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    PubMed    
    
    
    
100. TOMII D, Praz F, Windecker S
     Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
     Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
     PubMed    
     
     
     
101. PATEL KP, Baumbach A
     Timing treatment for tricuspid regurgitation.
     Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
     PubMed    
     
     
     
102. ACKLAND GL, Patel A, Abbott TEF, Begum S, et al
     Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial.
     Eur Heart J. 2023 Nov 7:ehad716. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. BOULET J, Mehra MR
     Crossing the chasm of donor organ recovery in heart transplantation.
     Eur Heart J. 2023 Nov 4:ehac707. doi: 10.1093.
     PubMed    
     
     
     
104. KIM H, Kang DY, Lee J, Choi Y, et al
     Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
     Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
     2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
     Eur Heart J. 2023;44:4310-4320.
     PubMed     Abstract available
     
     
     
106. CREA F
     Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
     Eur Heart J. 2023;44:4295-4299.
     PubMed    
     
     
     
107. KODALI S, Hahn RT, Makkar R, Makar M, et al
     Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
     Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2023
108. HARARI E, Landes U
     Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
     Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
     PubMed    
     
     
     
109. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
     Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
     Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
     PubMed    
     
     
     
110. ARORA S, Zimmermann FM, Solberg OG, Nytroen K, et al
     Prognostic value of intravascular ultrasound early after heart transplantation.
     Eur Heart J. 2023 Oct 18:ehad648. doi: 10.1093.
     PubMed    
     
     
     
111. WIJESURENDRA RS, Sardell R, Jayaram R, Samuel N, et al
     Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
     Eur Heart J. 2023 Oct 4:ehad640. doi: 10.1093.
     PubMed    
     
     
     
112. FARJAT-PASOS JI, Dumont E, Paradis JM
     Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
     Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
     PubMed    
     
     
     
113. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
     Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
     Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2023
114. VERGALLO R, Volpe M
     Light the FIRE of revascularization in older patients with myocardial infarction.
     Eur Heart J. 2023 Sep 28:ehad638. doi: 10.1093.
     PubMed    
     
     
     
115. BEYGUI F, Guillemot V, Saloux E
     Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
     Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
     PubMed    
     
     
     
116. KI YJ, Han K, Kim HS, Han JK, et al
     Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
     Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
     PubMed     Abstract available
     
     
     
117. BORLAUG BA, Schaff HV, Asirvatham SJ, Koepp KE, et al
     Surgical pericardiotomy to treat heart failure with preserved ejection fraction: a first clinical study.
     Eur Heart J. 2023 Sep 22:ehad620. doi: 10.1093.
     PubMed    
     
     
     
118. MOORE JP, Aboulhosn JA, Khairy P
     Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
     Eur Heart J. 2023;44:3228-3230.
     PubMed    
     
     
     
119. 
     Correction to: 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the Europ
     Eur Heart J. 2023 Sep 7:ehad577. doi: 10.1093.
     PubMed    
     
     
     
120. FENG S, Wu F, Pan X
     Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
     Eur Heart J. 2023;44:3199.
     PubMed    
     
     
     
121. CREA F
     TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
     Eur Heart J. 2023;44:3105-3109.
     PubMed    
     
     
     August 2023
122. BERRY C, McClure JD, Oldroyd KG
     Coronary revascularization guided by instantaneous wave-free ratio compared to fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials.
     Eur Heart J. 2023 Aug 27:ehad552. doi: 10.1093.
     PubMed    
     
     
     
123. EFTEKHARI A, Holck EN, Westra J, Olsen NT, et al
     Five-year major cardiovascular events are increased when coronary revascularization is guided by instantaneous wave-free ratio compared to fractional flow reserve: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials.
     Eur Heart J. 2023 Aug 27:ehad582. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
     Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
     Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
     PubMed     Abstract available
     
     
     
125. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
     TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
     Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
     PubMed     Abstract available
     
     
     
126. PRENDERGAST BD, Patterson T, Redwood S
     Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
     Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
     PubMed    
     
     
     
127. MCENTEGART M, Gori T
     How to treat left main coronary artery disease: the complementary lessons from trials and registries.
     Eur Heart J. 2023;44:2843-2845.
     PubMed    
     
     
     
128. PERSSON J, Yan J, Angeras O, Venetsanos D, et al
     PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
     Eur Heart J. 2023;44:2833-2842.
     PubMed     Abstract available
     
     
     
129. AL ZAIDI M, Nickenig G, Zimmer S
     Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
     Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
     PubMed    
     
     
     
130. VAN KLEI WA, van Waes JAR, Beattie WS
     Routine post-operative troponin surveillance after non-cardiac surgery: are we ready?
     Eur Heart J. 2023 Aug 1:ehad487. doi: 10.1093.
     PubMed    
     
     
     July 2023
131. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
     Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
     Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
     PubMed    
     
     
     
132. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
     Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
     Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. HAMILTON GW, Raman J, Moten S, Matalanis G, et al
     Radial artery vs. internal thoracic artery or saphenous vein grafts: 15-year results of the RAPCO trials.
     Eur Heart J. 2023;44:2406-2408.
     PubMed    
     
     
     
134. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
     Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
     Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
     PubMed     Abstract available
     
     
     
135. BADIMON L, Mendieta G, Vilahur G
     Statins revisited: therapeutic applications beyond lipid lowering?
     Eur Heart J. 2023;44:2332-2334.
     PubMed    
     
     
     
136. LORENZATTI D, Pina P, Slipczuk L
     Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
     Eur Heart J. 2023;44:2350.
     PubMed    
     
     
     June 2023
137. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
     Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
     Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. GOEL K, Shah P, Jones BM, Korngold E, et al
     Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
     Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. AMIN H, Noor HA, Bardooli F, Yousif N, et al
     Implementation of a national primary percutaneous coronary intervention program for ST-segment elevation myocardial infarction in the Kingdom of Bahrain: an inspiring success story from a centre of excellence.
     Eur Heart J. 2023 Jun 17:ehad329. doi: 10.1093.
     PubMed    
     
     
     
140. PEDICINO D, Vergallo R
     Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
     Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
     PubMed    
     
     
     
141. SMALL AM, Libby P
     Why Y? The Y chromosome may serve a cardiovascular purpose after all.
     Eur Heart J. 2023;44:1953-1955.
     PubMed    
     
     
     May 2023
142. HALVORSEN S, Mehilli J, Geisler T
     Continue or discontinue aspirin before non-cardiac surgery?
     Eur Heart J. 2023 May 8:ehad246. doi: 10.1093.
     PubMed    
     
     
     
143. HAN Y, Sun Z, Fan T
     Simultaneous percutaneous closure of aortic paravalvular leak and residual shunt of ventricular septal defect.
     Eur Heart J. 2023;44:1577.
     PubMed    
     
     
     April 2023
144. VERGALLO R, Liuzzo G
     Intravascular imaging to guide percutaneous coronary intervention of complex lesions: time to renovate guidelines?
     Eur Heart J. 2023 Apr 26:ehad243. doi: 10.1093.
     PubMed    
     
     
     
145. HALVORSEN S, Mehilli J, Mueller C
     The roles of cardiac troponins before non-cardiac surgery.
     Eur Heart J. 2023 Apr 26:ehad226. doi: 10.1093.
     PubMed    
     
     
     
146. BEN-BARUCH GOLAN Y, Zahger D
     Routine troponin testing before non-cardiac surgery: does the evidence justify the consequences?
     Eur Heart J. 2023 Apr 26:ehad227. doi: 10.1093.
     PubMed    
     
     
     
147. LEE J, Kim JS, Shim CY
     MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
     Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
     PubMed    
     
     
     
148. LIAKOPOULOS OJ, Kuhn EW, Hellmich M, Schlomicher M, et al
     Statin loading before coronary artery bypass grafting: a randomized trial.
     Eur Heart J. 2023 Apr 22:ehad238. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. PEDICINO D, Vergallo R
     Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
     Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
     PubMed    
     
     
     
150. TOMOAIA R, Sandu I, Beyer RS
     Fatal infective endocarditis early after TAVR.
     Eur Heart J. 2023;44:1478.
     PubMed    
     
     
     
151. GENTILE D, Iannaccone M, Chieffo A
     Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next?
     Eur Heart J. 2023;44:1357-1359.
     PubMed    
     
     
     
152. COLOMBO A, Leone PP
     Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
     Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
     PubMed    
     
     
     
153. MITSUI K, Fujino M, Noguchi T
     Left internal thoracic artery bypass graft.
     Eur Heart J. 2023;44:1284.
     PubMed    
     
     
     March 2023
154. KAGASE A, Yamamoto M, Tokuda T
     Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
     Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
     PubMed    
     
     
     
155. XIE Z, Zhu H
     A rare case of mitral regurgitation caused by primary aldosteronism.
     Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
     PubMed    
     
     
     
156. CHEN YH, Chang HH, Leu HB
     Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
     Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
     PubMed    
     
     
     
157. CIARDETTI N, Nardi G, Di Mario C
     Direct high-frequency intravascular ultrasound visualization of drug delivery after paclitaxel urea eluting balloon angioplasty.
     Eur Heart J. 2023;44:1096.
     PubMed    
     
     
     
158. HONDA Y, Nishihira K, Shibata Y, Asada Y, et al
     Early-phase restenosis following directional coronary atherectomy and paclitaxel-coated balloon angioplasty: a histopathological analysis.
     Eur Heart J. 2023;44:1098.
     PubMed    
     
     
     
159. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
     Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
     Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. CHUNG CJ, Otto CM
     Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
     Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
     PubMed    
     
     
     
161. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
     Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
     Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
     PubMed     Abstract available
     
     
     
162. RODES-CABAU J, Nuche J
     Are contemporary TAVI results influenced by hospital volume?
     Eur Heart J. 2023;44:868-870.
     PubMed    
     
     
     
163. CHEN J, Yang Y, Wei L
     One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
     Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
     PubMed    
     
     
     February 2023
164. 
     Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respi
     Eur Heart J. 2023 Feb 23:ehad005. doi: 10.1093.
     PubMed    
     
     
     
165. CHEN CB, Jarrett H, Goldman SM
     Candida endocarditis in a transcatheter aortic valve.
     Eur Heart J. 2023 Feb 13:ehad070. doi: 10.1093.
     PubMed    
     
     
     January 2023
166. 
     Corrigendum to: Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis.
     Eur Heart J. 2023 Jan 31:ehad047. doi: 10.1093.
     PubMed    
     
     
     
167. GAUDINO M, Di Franco A, Rong LQ, Piccini J, et al
     Postoperative atrial fibrillation: from mechanisms to treatment.
     Eur Heart J. 2023 Jan 31:ehad019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. PUELACHER C, Gualandro DM, Glarner N, Lurati Buse G, et al
     Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery.
     Eur Heart J. 2023 Jan 27:ehac798. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. ZHANG T, Yang X, Song J, Shi Y, et al
     Emergent transcatheter aortic valve implantation combined with enterectomy for acute decompensated heart failure caused by severe aortic stenosis and strangulated femoral hernia.
     Eur Heart J. 2023 Jan 26:ehad007. doi: 10.1093.
     PubMed    
     
     
     
170. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
     Factors influencing post-surgical survival in degenerative mitral regurgitation.
     Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. AHMAD Y, Howard JP, Arnold AD, Madhavan MV, et al
     Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.
     Eur Heart J. 2023 Jan 20:ehac642. doi: 10.1093.
     PubMed     Abstract available
     
     
     
172. PILGRIM T, Siontis GCM, Windecker S
     Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovation.
     Eur Heart J. 2023 Jan 20:ehac635. doi: 10.1093.
     PubMed    
     
     
     
173. KANAMURA T, Hashimoto T, Shiose A, Tsutsui H, et al
     Thrombus associated with locked-in atrial fibrillation in recipient remnant left atrium after heart transplantation.
     Eur Heart J. 2023 Jan 20:ehad008. doi: 10.1093.
     PubMed    
     
     
     
174. LEE G, Chikwe J, Milojevic M, Wijeysundera HC, et al
     ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.
     Eur Heart J. 2023 Jan 12:ehac803. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. CHIETERA F, Saia F, Palmerini T
     Post-traumatic acute aortic regurgitation due to cusp rupture in non-calcific bicuspid valve treated with ballon-expandable transcatheter heart valve.
     Eur Heart J. 2023 Jan 12:ehac805. doi: 10.1093.
     PubMed    
     
     
     
176. OMRAN H
     Troponin for risk stratification after CABG: just one piece of the puzzle.
     Eur Heart J. 2023;44:163-164.
     PubMed    
     
     
     
177. CHEN T, Zhou H, Guo J, Chen Y, et al
     Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions.
     Eur Heart J. 2023;44:166.
     PubMed    
     
     
     December 2022
178. 
     Erratum to: The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
     Eur Heart J. 2022 Dec 28:ehac815. doi: 10.1093.
     PubMed    
     
     
     
179. SALAUN E, Villeneuve J, Voisine P
     Unexpected find of native aortic leaflet thrombus during surgical myocardial revascularization.
     Eur Heart J. 2022;43:5064.
     PubMed    
     
     
     
180. ARFAEE M, Vis A, Kluin J
     Future technologies in total artificial heart development: can a robot become as good as a donor heart?
     Eur Heart J. 2022;43:4970-4972.
     PubMed    
     
     
     
181. MEHILLI J, Halvorsen S
     The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
     Eur Heart J. 2022 Dec 17:ehac703. doi: 10.1093.
     PubMed    
     
     
     
182. HOUEIJEH A, Domanski O, Bouzguenda I
     Multimodality fusion imaging to plan and to guide complex coronary fistula closure.
     Eur Heart J. 2022;43:4851.
     PubMed    
     
     
     
183. MONSUEZ JJ, Gatzov P, Ferreira-Gonzalez I, Alfonso F, et al
     Coronary interventions 2021: insights from the National Societies of Cardiology Journals of the European Society of Cardiology.
     Eur Heart J. 2022 Dec 7:ehac679. doi: 10.1093.
     PubMed    
     
     
     
184. COSTA F, Montalto C, Branca M, Hong SJ, et al
     Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
     Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. ANDREOTTI F, Geisler T, Collet JP, Gigante B, et al
     Acute, periprocedural and longterm antithrombotic therapy in older adults.
     Eur Heart J. 2022 Dec 7:ehac515. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. JAMAL J, Idris H, Faour A, Yang W, et al
     Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
     Eur Heart J. 2022 Dec 2:ehac661. doi: 10.1093.
     PubMed     Abstract available
     
     
     
187. HAN Y
     Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.
     Eur Heart J. 2022 Dec 2:ehac625. doi: 10.1093.
     PubMed    
     
     
     November 2022
188. SCOTTI A, Coisne A, Taramasso M, Granada JF, et al
     Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation.
     Eur Heart J. 2022 Nov 29:ehac735. doi: 10.1093.
     PubMed     Abstract available
     
     
     
189. WANG B, Lee RJ, Tao L
     First-in-human transcatheter endocardial alginate-hydrogel implantation for the treatment of heart failure.
     Eur Heart J. 2022 Nov 24:ehac671. doi: 10.1093.
     PubMed    
     
     
     
190. CREA F
     Controversies in cardiac surgery: left main coronary disease, arterial myocardial revascularization, and prosthetic valves in dialysis.
     Eur Heart J. 2022;43:4603-4605.
     PubMed    
     
     
     
191. KIM KS, Belley-Cote E, Whitlock RP
     What is the optimal prosthetic valve in dialysis?
     Eur Heart J. 2022;43:4657-4659.
     PubMed    
     
     
     
192. MOTOVSKA Z, Akin I
     The art of selection in coronary bypass grafting.
     Eur Heart J. 2022;43:4653-4656.
     PubMed    
     
     
     
193. TAGGART DP, Audisio K, Gerry S, Robinson NB, et al
     Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.
     Eur Heart J. 2022;43:4644-4652.
     PubMed     Abstract available
     
     
     
194. PATHAK S, Lai FY, Miksza J, Petrie MC, et al
     Surgical or Percutaneous Coronary Revascularisation for Heart Failure: An In Silico Model using Routinely Collected Health Data to Emulate a Clinical Trial.
     Eur Heart J. 2022 Nov 9. pii: 6815617. doi: 10.1093.
     PubMed     Abstract available
     
     
     
195. HEUTS S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, et al
     Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
     Eur Heart J. 2022 Nov 7. pii: 6807330. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2022
196. VERGALLO R, Volpe M
     Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR.
     Eur Heart J. 2022 Oct 26. pii: 6774407. doi: 10.1093.
     PubMed    
     
     
     
197. YANG Y, Xie L, Qian H, Cui K, et al
     Minimally invasive videoscope-assisted cardiac surgery for paroxysmal atrial tachycardia originating from right atrial appendage.
     Eur Heart J. 2022 Oct 26. pii: 6774389. doi: 10.1093.
     PubMed    
     
     
     
198. MAN JP, Bouma BJ, Schuuring MJ
     Fusion imaging in preoperative planning of mitral valve surgery to prevent injury of the left circumflex artery.
     Eur Heart J. 2022 Oct 22. pii: 6769829. doi: 10.1093.
     PubMed    
     
     
     
199. ARMILLOTTA M, Foa A, Pizzi C
     Cardiac troponin elevation after coronary artery bypass graft: improving risk stratification.
     Eur Heart J. 2022 Oct 20. pii: 6763997. doi: 10.1093.
     PubMed    
     
     
     
200. VERGALLO R, Liuzzo G
     The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
     Eur Heart J. 2022 Oct 10. pii: 6754626. doi: 10.1093.
     PubMed    
     
     
     September 2022
201. ARMSTRONG PW, Bates ER, Gaudino M
     Left main coronary disease: evolving management concepts.
     Eur Heart J. 2022 Sep 29. pii: 6731216. doi: 10.1093.
     PubMed     Abstract available
     
     
     
202. TEN BERG J, Rocca B, Angiolillo DJ, Hayashida K, et al
     The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties.
     Eur Heart J. 2022 Sep 21. pii: 6708420. doi: 10.1093.
     PubMed     Abstract available
     
     
     
203. 
     Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
     Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
     PubMed    
     
     
     
204. VERGALLO R, Patrono C
     Antiplatelet therapy to prevent graft failure after coronary artery bypass graft: aspirin monotherapy for most, DAPT for selected few.
     Eur Heart J. 2022 Sep 14. pii: 6697011. doi: 10.1093.
     PubMed    
     
     
     
205. HAN Y
     Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement.
     Eur Heart J. 2022 Sep 14. pii: 6697004. doi: 10.1093.
     PubMed    
     
     
     
206. KO KY, Hong GR, Lee SH
     Novel technique of sutureless pulmonic valve replacement for quadricuspid pulmonic valve with huge pulmonary artery aneurysm.
     Eur Heart J. 2022;43:3183.
     PubMed    
     
     
     August 2022
207. HALVORSEN S, Mehilli J, Cassese S, Hall TS, et al
     2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
     Eur Heart J. 2022 Aug 26. pii: 6675076. doi: 10.1093.
     PubMed    
     
     
     
208. ZHANG X, Wang H, Guo Y, Peng Y, et al
     Aortic root 'sink down' caused mitral stenosis after aortic valve replacement: a rare presentation of Bechet's disease.
     Eur Heart J. 2022 Aug 18. pii: 6670978. doi: 10.1093.
     PubMed    
     
     
     
209. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
     Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
     Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
     PubMed    
     
     
     
210. CREA F
     Challenges in the management of aortic stenosis, multiple valve disease, culture-negative endocarditis, and cardiac surgery during pregnancy.
     Eur Heart J. 2022;43:2715-2719.
     PubMed    
     
     
     
211. KONG WKF, Salsano A, Giacobbe DR, Popescu BA, et al
     Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry.
     Eur Heart J. 2022;43:2770-2780.
     PubMed     Abstract available
     
     
     
212. HAHN RT, Pibarot P, Otto CM
     Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
     Eur Heart J. 2022;43:2767-2769.
     PubMed    
     
     
     
213. ANDREOTTI F, Massetti M, Ten Berg J
     Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS.
     Eur Heart J. 2022;43:2798-2800.
     PubMed    
     
     
     
214. ZHAO ZG, Chen F, Wei X, Feng Y, et al
     Transcatheter mitral valve implantation in severely calcified rheumatic mitral stenosis without annular calcification.
     Eur Heart J. 2022 Aug 1. pii: 6652910. doi: 10.1093.
     PubMed    
     
     
     July 2022
215. ORTEGA-PAZ L, Angiolillo DJ
     Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention.
     Eur Heart J. 2022 Jul 21. pii: 6647789. doi: 10.1093.
     PubMed    
     
     
     
216. CREA F
     The challenge of risk stratification in aortic aneurysms, congenital heart disease, and coronary bypass surgery.
     Eur Heart J. 2022;43:2343-2346.
     PubMed    
     
     
     
217. GAUDINO M, Farkouh ME, Stone GW
     Left main revascularization: an evidence-based reconciliation.
     Eur Heart J. 2022;43:2421-2424.
     PubMed    
     
     
     
218. RYCHIK J
     You can only change what you measure: an argument for more detailed characterization in the Fontan circulation.
     Eur Heart J. 2022;43:2385-2387.
     PubMed    
     
     
     
219. INAI K, Inuzuka R, Ono H, Nii M, et al
     Predictors of long-term mortality among perioperative survivors of Fontan operation.
     Eur Heart J. 2022;43:2373-2384.
     PubMed     Abstract available
     
     
     June 2022
220. VERGALLO R, Volpe M
     The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.
     Eur Heart J. 2022 Jun 25. pii: 6617779. doi: 10.1093.
     PubMed    
     
     
     
221. CREA F
     The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
     Eur Heart J. 2022;43:2165-2169.
     PubMed    
     
     
     
222. KHAIRY P, Silka MJ, Moore JP, DiNardo JA, et al
     Sudden cardiac death in congenital heart disease.
     Eur Heart J. 2022;43:2103-2115.
     PubMed     Abstract available
     
     
     
223. HAN Y
     Current clinical data and experience of TAVR in China.
     Eur Heart J. 2022;43:2087-2088.
     PubMed    
     
     
     
224. BRAUNWALD E
     Cardiac xenotransplantation: a new path for the treatment of advanced heart failure?
     Eur Heart J. 2022 Jun 4. pii: 6601572. doi: 10.1093.
     PubMed    
     
     
     
225. BELLUSCHI I, Buzzatti N, Denti P, Maisano F, et al
     Transcatheter lithotripsy to facilitate post-dilatation of underexpanded aortic transcatheter heart valve.
     Eur Heart J. 2022;43:2081.
     PubMed    
     
     
     May 2022
226. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
     Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
     Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
     PubMed     Abstract available
     
     
     
227. COLLET JP, Van Belle E, Thiele H, Berti S, et al
     Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
     Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
     PubMed     Abstract available
     
     
     
228. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
     Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
     Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
     PubMed     Abstract available
     
     
     
229. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
     Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
     Eur Heart J. 2022;43:1884.
     PubMed    
     
     
     
230. GALIUTO L, Massetti M
     To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
     Eur Heart J. 2022;43:1792-1793.
     PubMed    
     
     
     
231. VAN STEENBERGEN GJ, Tsang QHY, van der Heijden OWH, Vart P, et al
     Timing of cardiac surgery during pregnancy: a patient-level meta-analysis.
     Eur Heart J. 2022 May 13. pii: 6585605. doi: 10.1093.
     PubMed     Abstract available
     
     
     
232. BEDEIR K, Robichaux RP, Gleason TG
     Surgical whole valve embolization 15 years after implantation.
     Eur Heart J. 2022;43:1685.
     PubMed    
     
     
     
233. JANG SJ, Chen YH, Shen TC
     Pitfalls in recapture or repositioning of Evolut system using cusp overlap technique.
     Eur Heart J. 2022;43:1684.
     PubMed    
     
     
     April 2022
234. WINDECKER S, Okuno T, Unbehaun A, Mack M, et al
     Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
     Eur Heart J. 2022 Apr 25. pii: 6572863. doi: 10.1093.
     PubMed     Abstract available
     
     
     
235. DAYAN V, Gomes WJ
     The new ESC/EACTS recommendations for transcatheter aortic valve implantation go too far.
     Eur Heart J. 2022 Apr 25. pii: 6572861. doi: 10.1093.
     PubMed    
     
     
     
236. THIELE H, Collet JP, Leon M, Mehran R, et al
     The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
     Eur Heart J. 2022 Apr 25. pii: 6572862. doi: 10.1093.
     PubMed    
     
     
     
237. CRESPO-LEIRO MG, Costanzo MR, Gustafsson F, Khush KK, et al
     Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies.
     Eur Heart J. 2022 Apr 20. pii: 6571226. doi: 10.1093.
     PubMed     Abstract available
     
     
     
238. CALCAGNO S, Di Pietro R, Biondi-Zoccai G, Versaci F, et al
     Cerebral protection device out of transcatheter heart procedures: a bridge to surgery.
     Eur Heart J. 2022;43:1598.
     PubMed    
     
     
     
239. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
     Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
     Eur Heart J. 2022;43:1599.
     PubMed    
     
     
     
240. 
     Corrigendum to: P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
     Eur Heart J. 2022 Apr 8. pii: 6565204. doi: 10.1093.
     PubMed    
     
     
     
241. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
     Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
     Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2022
242. CREA F
     Percutaneous coronary intervention vs. coronary artery bypass graft: the saga continues.
     Eur Heart J. 2022;43:1273-1276.
     PubMed    
     
     
     
243. HAN Y, Li Y
     Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
     Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
     PubMed    
     
     
     
244. THYGESEN K, Jaffe AS
     Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
     Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
     PubMed    
     
     
     
245. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
     P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
     Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2022
246. LIUZZO G, Volpe M
     Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
     Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
     PubMed    
     
     
     
247. RUDOLPH V
     Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
     Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.
     PubMed    
     
     
     
248. GIANNITSIS E, Frey N
     Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best.
     Eur Heart J. 2022 Feb 17. pii: 6530230. doi: 10.1093.
     PubMed    
     
     
     
249. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
     High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
     Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
     PubMed     Abstract available
     
     
     
250. SCHMIADY MO, Carrel T, Sigler M, Eildermann K, et al
     Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup.
     Eur Heart J. 2022 Feb 15. pii: 6528555. doi: 10.1093.
     PubMed    
     
     
     
251. COLOMBO A, Maisano F
     A new tool for the forgotten valve: a score to predict the risk of surgery.
     Eur Heart J. 2022;43:663-665.
     PubMed    
     
     
     
252. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
     Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
     Eur Heart J. 2022;43:666-679.
     PubMed     Abstract available
     
     
     
253. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
     Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
     Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
     PubMed     Abstract available
     
     
     
254. IUNG B, Urena M
     New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly?
     Eur Heart J. 2022;0.
     PubMed    
     
     
     
255. DE CATERINA R, Liga R, Boden WE
     Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
     Eur Heart J. 2022;43:387-390.
     PubMed    
     
     
     
256. FENG D, Zhang C, Wang J, Lin B, et al
     Simultaneous transcatheter aortic mitral and tricuspid valve-in-valve implantation.
     Eur Heart J. 2022;43:433.
     PubMed    
     
     
     
257. BEOHAR N, Ailawadi G, Kotinkaduwa LN, Redfors B, et al
     Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
     Eur Heart J. 2022 Feb 3. pii: 6521532. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
258. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
     Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
     Eur Heart J. 2022 Jan 28. pii: 6516865. doi: 10.1093.
     PubMed    
     
     
     
259. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
     Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
     Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
     PubMed     Abstract available
     
     
     
260. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
     Myocardial viability testing: all STICHed up, or about to be REVIVED?
     Eur Heart J. 2022;43:118-126.
     PubMed     Abstract available
     
     
     December 2021
261. BENEDETTO U, Dimagli A, Kaura A, Sinha S, et al
     Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit.
     Eur Heart J. 2021;43:44-52.
     PubMed     Abstract available
     
     
     
262. WANG R, Serruys PW, Gao C, Hara H, et al
     Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
     Eur Heart J. 2021;43:56-67.
     PubMed     Abstract available
     
     
     
263. BODEN WE, De Caterina R, Taggart DP
     Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility.
     Eur Heart J. 2021;43:68-70.
     PubMed    
     
     
     
264. BULLUCK H, Thygesen K, Hausenloy DJ
     Prognostically relevant cardiac troponin elevations with percutaneous coronary interventions.
     Eur Heart J. 2021 Dec 21. pii: 6471438. doi: 10.1093.
     PubMed    
     
     
     
265. ALFONSO F, Rivero F, Segovia-Cubero J
     Early diagnosis of cardiac allograft vasculopathy: biopsy, liquid biopsy, non-invasive imaging, coronary imaging, or coronary physiology?
     Eur Heart J. 2021;42:4930-4933.
     PubMed    
     
     
     
266. CREA F
     Percutaneous coronary interventions: more complex than fixing stenoses.
     Eur Heart J. 2021;42:4607-4611.
     PubMed    
     
     
     
267. NAVARESE EP, Andreotti F
     Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes.
     Eur Heart J. 2021;42:4699-4700.
     PubMed    
     
     
     
268. ABELLAS-SEQUEIROS M, Pardo Sanz A, Sanchez-Recalde A, Sanmartin-Fernandez M, et al
     Traumatic coronary artery dissection with total occlusion of left descending coronary artery: to stent or not to stent.
     Eur Heart J. 2021;42:4701.
     PubMed    
     
     
     
269. BROWN DL, Boden WE
     Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?
     Eur Heart J. 2021;42:4652-4655.
     PubMed    
     
     
     
270. ERLINGE D, Gotberg M
     We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting?
     Eur Heart J. 2021;42:4669-4670.
     PubMed    
     
     
     November 2021
271. BAUMGARTNER H
     Aortic stenosis management in 2021: better teaming up than fighting between specialties.
     Eur Heart J. 2021 Nov 28. pii: 6445126. doi: 10.1093.
     PubMed    
     
     
     
272. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
     Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
     Eur Heart J. 2021 Nov 25. pii: 6439994. doi: 10.1093.
     PubMed     Abstract available
     
     
     
273. EGGERS KM, James SK, Lindahl B
     Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
     Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
     PubMed    
     
     
     
274. CHIKWE J, Alfieri OR
     The optimal strategy for multivessel coronary revascularization.
     Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
     PubMed    
     
     
     
275. MICHOWITZ Y, Kronborg MB, Glikson M, Nielsen JC, et al
     The '10 commandments' for the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy.
     Eur Heart J. 2021;42:4295.
     PubMed    
     
     
     
276. PASQUALIN G, Sturla F, D'Aiello AF, Chessa M, et al
     Mixed reality navigation of a systemic venous baffle obstruction: unravelling the percutaneous approach in atrial switch operation.
     Eur Heart J. 2021;42:4284.
     PubMed    
     
     
     October 2021
277. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
     Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
     Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
     PubMed     Abstract available
     
     
     
278. ESCANED J, Cao D, Baber U, Nicolas J, et al
     Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
     Eur Heart J. 2021 Oct 18. pii: 6400337. doi: 10.1093.
     PubMed     Abstract available
     
     
     
279. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
     Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
     Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2021
280. DREYFUS J, Audureau E, Bohbot Y, Coisne A, et al
     TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
     Eur Heart J. 2021 Sep 29. pii: 6377884. doi: 10.1093.
     PubMed     Abstract available
     
     
     
281. VAHANIAN A, Praz F, Milojevic M, Beyersdorf F, et al
     The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease.
     Eur Heart J. 2021 Sep 16. pii: 6371303. doi: 10.1093.
     PubMed    
     
     
     
282. MANCINI D, Gibson GT, Rangasamy S
     Improving survival after heart transplantation despite increasing complexity.
     Eur Heart J. 2021 Sep 3. pii: 6363624. doi: 10.1093.
     PubMed    
     
     
     
283. MESSIKA-ZEITOUN D, Hibbert B, Chan V
     'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
     Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
     PubMed    
     
     
     August 2021
284. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
     Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
     Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
     PubMed     Abstract available
     
     
     
285. VAHANIAN A, Beyersdorf F, Praz F, Milojevic M, et al
     2021 ESC/EACTS Guidelines for the management of valvular heart disease.
     Eur Heart J. 2021 Aug 28. pii: 6358470. doi: 10.1093.
     PubMed    
     
     
     
286. KLOECKNER M, Guihaire J, Hascoet S
     Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
     Eur Heart J. 2021;42:3103-3104.
     PubMed    
     
     
     
287. LAURI FM, Fernandez-Golfin C, Zamorano JL, Sanchez-Recalde A, et al
     Coronary compression caused by extrinsic adventitial damage: case of an early complication of trans-catheter tricuspid annuloplasty with cardioband device.
     Eur Heart J. 2021 Aug 18. pii: 6354189. doi: 10.1093.
     PubMed    
     
     
     
288. TEN BERG J
     Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
     Eur Heart J. 2021 Aug 9. pii: 6346754. doi: 10.1093.
     PubMed    
     
     
     
289. DANGAS G, Nicolas J, Mehran R
     Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.
     Eur Heart J. 2021 Aug 9. pii: 6346755. doi: 10.1093.
     PubMed    
     
     
     
290. ZHU Y, Lingala B, Baiocchi M, Toro Arana V, et al
     The Stanford experience of heart transplantation over five decades.
     Eur Heart J. 2021 Aug 1. pii: 6333296. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2020
291. DELGADO V, Ajmone Marsan N, Bax JJ
     The difficult decision of when and in whom to perform isolated tricuspid valve surgery.
     Eur Heart J. 2020 Sep 27. pii: 5912178. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.